Dapivirine (TMC120)

Catalog No.S2914

Dapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates. Phase 3.

Price Stock Quantity  
USD 190 In stock
USD 147 In stock
USD 470 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Dapivirine (TMC120) Chemical Structure

Dapivirine (TMC120) Chemical Structure
Molecular Weight: 329.4

Validation & Quality Control

Quality Control & MSDS

Related Compound Libraries

Dapivirine (TMC120) is available in the following compound libraries:

Product Information

  • Compare Reverse Transcriptase Inhibitors
    Compare Reverse Transcriptase Products
  • Research Area

Product Description

Biological Activity

Description Dapivirine (TMC120) is a non-nucleoside inhibitor for HIV reverse transcriptase with IC50 of 24 nM, inhibits a broad panel of HIV-1 isolates from different classes, inclucing a wide range of NNRTI-resistant isolates. Phase 3.
Targets HIV reverse transcriptase [1]
IC50 24 nM
In vitro Dapivirine prevents HIV-induced syncytium formation in the nanomolar range and shows a low cytostatic activity. Dapivirine apparently blocks HIV-1 infection in the primary cultures at a 10 nM concentration, but secondary cultures reveals that a 100 nM concentration is needed to completely prevent proviral integration. [1] Dapivirine is well tolerated by epithelial cells, T cells, macrophages, and cervical tissue explants with CC50 (50% cytotoxic concentration) of 10 μM to 20 μM. Dapivirine potently inhibits infection by both X4- and R5-utilizing HIV-1 strains with IC50 of 1.46 nM in cell-based assays. Dapivirine potently inhibits HIV-1BaL infection of human ectocervical explant tissue in a dose-dependent manner, as evaluated by the reduction in both p24 release and provirus content in cultured explants. Dapivirine inhibits the transmission of virus to permissive T cells in a dose-dependent manner, with an IC50 of 0.1 nM. Dapivirine results in significant inhibition of HIV infection when explants are challenged with virus immediately with IC90 of 100 nM. Dapivirine is also able to inhibit viral dissemination by migratory cells. [2]
In vivo Dapivirine-containing gel at vaginal level inhibits cell-associated HIV infection in mice. [3] More placebo (7 of 12) than Dapivirine (3 of 24) gel users has positive vaginal swab results, with white blood cells being the most common finding. Dapivirine (0.05%) results in Cmax of 715 pg/mL, AUC of 15 ng×h/mL and T1/2 of 89.87 hours in plasma after 14 days post-dose. Mean Dapivirine (0.05%) concentrations in vaginal fluids collected at the introitus, mid vagina, and cervix are in the range of 62-265 μg/g on day 1. [4]

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDog
Weight (kg)
Body Surface Area (m2)0.0070.0250.
Km factor36128520
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)


[1] Van Herrewege Y, et al. Antimicrob Agents Chemother, 2004, 48(1), 337-339.

[2] Fletcher P, et al. Antimicrob Agents Chemother, 2009, 53(2), 487-495.

view more

Clinical Trial Information( data from http://clinicaltrials.gov, updated on 2016-07-23)

NCT Number Recruitment Conditions Sponsor
Start Date Phases
NCT02658227 Not yet recruiting HIV Infections International Partnership for Microbicides, Inc. February 2016 Phase 1
NCT02808949 Active, not recruiting Human Immunodeficiency Virus International Partnership for Microbicides, Inc. February 2015 Phase 1
NCT02028338 Enrolling by invitation HIV Prevention International Partnership for Microbicides, Inc.|Microbic  ...more International Partnership for Microbicides, Inc.|Microbicide Trials Network|National Institutes of Health (NIH) March 2014 Phase 2
NCT02010593 Completed Safety/PK and Adherence/Acceptability International Partnership for Microbicides, Inc.|National  ...more International Partnership for Microbicides, Inc.|National Institute of Allergy and Infectious Diseases (NIAID) December 2013 Phase 2
NCT01952561 Not yet recruiting Pharmacokinetics International Partnership for Microbicides, Inc. November 2013 Phase 1

view more

Chemical Information

Download Dapivirine (TMC120) SDF
Molecular Weight (MW) 329.4


CAS No. 244767-67-7
Storage 3 years -20℃powder
6 months-80℃in solvent
Synonyms N/A
Solubility (25°C) * In vitro DMSO 34 mg/mL (103.21 mM)
Water <1 mg/mL (<1 mM)
Ethanol <1 mg/mL (<1 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Benzonitrile, 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]-

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related Reverse Transcriptase Products

  • Tenofovir Alafenamide (GS-7340)

    Tenofovir Alafenamide (GS-7340) is a prodrug of tenofovir, which is a reverse transcriptase inhibitor, used to treat HIV and Hepatitis B.

  • Cabotegravir (GSK744, GSK1265744)

    Cabotegravir (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor against a broad range of HIV subtypes, and inhibits the HIV-1 integrase catalyzed strand transfer reaction with IC50 of 3.0 nM. Phase 2.

  • Tenofovir Disoproxil Fumarate

    Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral drugs, it inhibits the activity of HIV reverse transcriptase by competing with the natural substrate deoxyadenosine 5’-triphosphate and, after incorporation into DNA, by DNA chain termination.

  • Zidovudine

    Zidovudine (ZDV) is a nucleoside analogue reverse transcriptase inhibitor, used to treat HIV.

  • Lamivudine

    Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS.

  • Tenofovir

    Tenofovir blocks reverse transcriptase and hepatitis B virus infections.

    Features:Tenofovir disoproxil fumarate is the prodrug form of tenofovir.

  • Emtricitabine

    Emtricitabine (FTC) is a nucleoside reverse transcriptase inhibitor that has activity against both human immunodeficiency virus (HIV) and hepatitis B virus.

  • Rilpivirine

    Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI), and used to treat HIV-1 infection.

  • Nevirapine

    Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection and AIDS.

Recently Viewed Items

Tags: buy Dapivirine (TMC120) | Dapivirine (TMC120) supplier | purchase Dapivirine (TMC120) | Dapivirine (TMC120) cost | Dapivirine (TMC120) manufacturer | order Dapivirine (TMC120) | Dapivirine (TMC120) distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
Contact Us